Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.

Bax HI, de Vogel CP, Mouton JW, de Steenwinkel JEM.

J Antimicrob Chemother. 2019 Jun 24. pii: dkz267. doi: 10.1093/jac/dkz267. [Epub ahead of print]

PMID:
31236595
2.

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

Clewe O, Wicha SG, de Vogel CP, de Steenwinkel JEM, Simonsson USH.

J Antimicrob Chemother. 2018 Feb 1;73(2):437-447. doi: 10.1093/jac/dkx380.

3.

The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.

Bax HI, Bakker-Woudenberg IAJM, de Vogel CP, van der Meijden A, Verbon A, de Steenwinkel JEM.

Tuberculosis (Edinb). 2017 Jul;105:80-85. doi: 10.1016/j.tube.2017.04.010. Epub 2017 Apr 27.

PMID:
28610791
4.

Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.

de Knegt GJ, van der Meijden A, de Vogel CP, Aarnoutse RE, de Steenwinkel JE.

Int J Antimicrob Agents. 2017 Mar;49(3):302-307. doi: 10.1016/j.ijantimicag.2016.11.027. Epub 2017 Feb 2.

PMID:
28162983
5.

Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice.

van den Berg S, de Vogel CP, van Belkum A, Bakker-Woudenberg IA.

PLoS One. 2015 Jun 10;10(6):e0129150. doi: 10.1371/journal.pone.0129150. eCollection 2015.

6.

Serological profiles in nursery piglets colonized with Staphylococcus aureus.

Crombé F, Vanderhaeghen W, de Vogel CP, Van Wamel WJ, Barbé K, Hermans K, Haesebrouck F, Butaye P.

Vet Res. 2013 Jan 22;44:4. doi: 10.1186/1297-9716-44-4.

7.

High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus.

van der Kooi-Pol MM, de Vogel CP, Westerhout-Pluister GN, Veenstra-Kyuchukova YK, Duipmans JC, Glasner C, Buist G, Elsinga GS, Westra H, Bonarius HPJ, Groen H, van Wamel WJB, Grundmann H, Jonkman MF, van Dijl JM.

J Invest Dermatol. 2013 Mar;133(3):847-850. doi: 10.1038/jid.2012.347. Epub 2012 Sep 27. No abstract available.

8.

Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.

Verhaegh SJ, Stol K, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, van Belkum A, Hermans PW, Hays JP.

Clin Vaccine Immunol. 2012 Jun;19(6):914-8. doi: 10.1128/CVI.05630-11. Epub 2012 Apr 25.

9.

Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.

Prevaes SM, van Wamel WJ, de Vogel CP, Veenhoven RH, van Gils EJ, van Belkum A, Sanders EA, Bogaert D.

Infect Immun. 2012 Jun;80(6):2186-93. doi: 10.1128/IAI.00037-12. Epub 2012 Mar 26.

10.

Rhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineages.

van den Berg S, van Wamel WJ, Snijders SV, Ouwerling B, de Vogel CP, Boelens HA, Willems RJ, Huijsdens XW, Verreck FA, Kondova I, Heidt PJ, Verbrugh HA, van Belkum A.

PLoS One. 2011;6(10):e26170. doi: 10.1371/journal.pone.0026170. Epub 2011 Oct 20. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/bc0581bd-5ef5-4116-b3b6-6fc6c5eb197c.

11.

Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection.

Verkaik NJ, Nguyen DT, de Vogel CP, Moll HA, Verbrugh HA, Jaddoe VW, Hofman A, van Wamel WJ, van den Hoogen BG, Buijs-Offerman RM, Ludlow M, de Witte L, Osterhaus AD, van Belkum A, de Swart RL.

Clin Microbiol Infect. 2011 Dec;17(12):1840-4. doi: 10.1111/j.1469-0691.2011.03480.x. Epub 2011 Aug 30.

12.

Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants.

Verhaegh SJ, de Vogel CP, Riesbeck K, Lafontaine ER, Murphy TF, Verbrugh HA, Jaddoe VW, Hofman A, Moll HA, van Belkum A, Hays JP.

Vaccine. 2011 Aug 5;29(34):5603-10. doi: 10.1016/j.vaccine.2011.06.019. Epub 2011 Jun 23.

PMID:
21704103
13.

Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.

Lebon A, Verkaik NJ, Labout JA, de Vogel CP, Hooijkaas H, Verbrugh HA, van Wamel WJ, Jaddoe VW, Hofman A, Hermans PW, Ma J, Mitchell TJ, Moll HA, van Belkum A.

Infect Immun. 2011 Apr;79(4):1680-7. doi: 10.1128/IAI.01379-10. Epub 2011 Jan 31.

14.

A multiplex assay for the quantification of antibody responses in Staphylococcus aureus infections in mice.

van den Berg S, Bowden MG, Bosma T, Buist G, van Dijl JM, van Wamel WJ, de Vogel CP, van Belkum A, Bakker-Woudenberg IA.

J Immunol Methods. 2011 Feb 28;365(1-2):142-8. doi: 10.1016/j.jim.2010.12.013. Epub 2010 Dec 23.

15.

Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins.

Shoma S, Verkaik NJ, de Vogel CP, Hermans PW, van Selm S, Mitchell TJ, van Roosmalen M, Hossain S, Rahman M, Endtz HP, van Wamel WJ, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):521-6. doi: 10.1007/s10096-010-1113-x. Epub 2010 Nov 18.

16.

The inverse correlation between Staphylococcus aureus and Streptococcus pneumoniae colonization in infants is not explained by differences in serum antibody levels in the Generation R Study.

Lebon A, Verkaik NJ, de Vogel CP, Hooijkaas H, Verbrugh HA, van Wamel WJ, Jaddoe VW, Hofman A, Hermans PW, Mitchell TJ, Moll HA, van Belkum A.

Clin Vaccine Immunol. 2011 Jan;18(1):180-3. doi: 10.1128/CVI.00357-10. Epub 2010 Nov 17.

17.

Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization.

Verkaik NJ, Benard M, Boelens HA, de Vogel CP, Nouwen JL, Verbrugh HA, Melles DC, van Belkum A, van Wamel WJ.

Clin Microbiol Infect. 2011 Mar;17(3):343-8. doi: 10.1111/j.1469-0691.2010.03227.x.

18.

Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.

Verkaik NJ, Boelens HA, de Vogel CP, Tavakol M, Bode LG, Verbrugh HA, van Belkum A, van Wamel WJ.

Eur J Clin Microbiol Infect Dis. 2010 May;29(5):509-18. doi: 10.1007/s10096-010-0888-0. Epub 2010 Feb 26.

19.

Immunogenicity of toxins during Staphylococcus aureus infection.

Verkaik NJ, Dauwalder O, Antri K, Boubekri I, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJ.

Clin Infect Dis. 2010 Jan 1;50(1):61-8. doi: 10.1086/648673.

PMID:
19947854
20.

Induction of antibodies by Staphylococcus aureus nasal colonization in young children.

Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Verbrugh HA, Jaddoe VW, Hofman A, Moll HA, van Belkum A, van Wamel WJ.

Clin Microbiol Infect. 2010 Aug;16(8):1312-7. doi: 10.1111/j.1469-0691.2009.03073.x. Epub 2009 Oct 14.

21.

Reclassification of Staphylococcus aureus nasal carriage types.

van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF.

J Infect Dis. 2009 Jun 15;199(12):1820-6. doi: 10.1086/599119.

PMID:
19419332
22.

Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.

Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJ.

J Infect Dis. 2009 Mar 1;199(5):625-32. doi: 10.1086/596743.

PMID:
19199541

Supplemental Content

Loading ...
Support Center